Cancer Network Podcasts
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 11:20:50
- Mas informaciones
Informações:
Sinopsis
Interviews with experts on the top news and controversies in the field of oncology today.
Episodios
-
ONS: Infection Risk, Prevention, and Management
29/04/2013 Duración: 11minIn this interview, Laura Zitella will be discussing challenges and considerations for management and prevention of infection in the oncology setting—in both patients with solid tumors and those with hematologic malignancies.
-
ONS: Genetics and Genomics Matters
25/04/2013 Duración: 15minThis interview covers standards for healthcare provider competency in offering comprehensive genetic services, and highlighting genetics/genomics resources for nurses.
-
ONS: Understanding Spirituality
24/04/2013 Duración: 13minIn this interview, Tami Borneman, who is presenting a poster at the 38th Annual ONS Congress, will discuss spirituality: what it means, and how spiritual interventions can benefit patients with cancer.
-
Patient Quality of Life Part II
12/04/2013 Duración: 12minThis interview covers symptom management and quality-of-life outcomes in cancer clinical trials, which are being incorporated more readily as secondary and sometimes primary trial endpoints.
-
AACR: Lung Cancer Therapy Innovations
05/04/2013 Duración: 10minIn this interview, ahead of the AACR annual meeting, we speak with Dr. Julie Brahmer, of Johns Hopkins School of Medicine, who is giving a presentation on immunotherapy in lung cancer, and is one of the clinical investigators of the extensive phase I trial of the anti–PD-1 antibody nivolumab.
-
Patient Quality of Life Part I
29/03/2013 Duración: 13minThis interview covers symptom management and quality-of-life outcomes in cancer clinical trials, which are being incorporated more readily as secondary and sometimes primary trial endpoints.
-
Treatment Combinations for HER2-Postive Breast Cancer
06/03/2013 Duración: 12minAs part of our coverage for the 30th Annual Miami Breast Cancer Conference, we bring you an interview with Dr. Mark Pegram, director of the breast cancer program at the Stanford Women’s Cancer Center and codirector of the molecular therapeutics program. Dr. Pegram will be discussing the potential for novel HER2 combination therapies at the conference.
-
Social Media for Oncologists
27/02/2013 Duración: 13minIn this interview we discuss the dissemination of research results, clinical trials, and other oncology news using social media, as well as what type of media oncologists use, and how useful and relevant this type of information is for most oncologists.
-
Status of HPV-Related Cancers and Vaccination Trends
21/02/2013 Duración: 13minIn this interview we discuss HPV-associated cancers, which are on the rise, and the low vaccination coverage for HPV with Edgar Simard, PhD, MPH, senior epidemiologist of surveillance research, who studies the impact of prevention and screening on cancer incidence at the American Cancer Society.
-
ASCO GU: Prostate Cancer
13/02/2013 Duración: 14minAhead of the ASCO GU meeting, we spoke with two symposium committee members, Dr. Mack Roach, of the University of California, San Francisco, and Dr. Hans T. Chung, of the University of Toronto, about early treatment and surveillance of prostate cancer patients.
-
Novel Multiple Myeloma Treatments and Agents in Development
31/01/2013 Duración: 11minIn this interview we discuss the current management and latest treatments and agents in development for multiple myeloma with Dr. Kenneth Anderson of the Dana-Farber Cancer Institute.
-
ASCO GI: Gastrointestinal Cancers
24/01/2013 Duración: 08minIn this interview we discuss the latest treatments and research for gastrointestinal cancers with Dr. Cathy Eng, associate professor, department of gastrointestinal medical oncology, The University of Texas MD Anderson Cancer Center.
-
Latest Treatment and Research for Chronic Myeloid Leukemia
24/12/2012 Duración: 15minIn this interview we discuss the latest chronic myeloid leukemia treatment and research with Dr. Michael Deininger, chief of the division of hematology at the University of Utah School of Medicine.
-
Patient Expectations About Their Cancer Treatment
20/12/2012 Duración: 10minIn this interview we discuss what patients expect from their cancer treatment with Deborah Schrag, MD, MPH, associate professor at Harvard Medical School. Dr. Schrag recently published a study that aimed to discover how patients with advanced cancer understand the purpose of their chemotherapy treatment.
-
ASH: Repurposed Drugs Show Promise in Multiple Myeloma
10/12/2012 Duración: 05minToday we speak with Steven T. Rosen, MD, about a couple of the projects he and his group are working on, repurposing old drugs for the treatment of multiple myeloma, that will be presented this year at ASH.
-
SABCS: Using Molecular Assays
04/12/2012 Duración: 13minTo kick off SABCS 2012, we discuss the use of molecular testing for the diagnosis and treatment of breast cancer patients in the clinical setting with Dr. Antonio Wolff of the Kimmel Cancer Center at Johns Hopkins University, one of the presenter's during the "Practical Use of Molecular Profiling" session at this year's symposium.
-
Advances in Metastatic Melanoma Care
12/11/2012 Duración: 16minIn this podcast we discuss the recent advances in the management and treatment of metastatic melanoma with Jeffrey Sosman, MD, medical oncologist and director of the Melanoma and Tumor Immunotherapy Program at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee.
-
Palliative Care for Oncology Patients
02/11/2012 Duración: 14minIn this podcast we discuss integrating palliative care into standard oncology care with Thomas J. Smith, director of palliative medicine at Sidney Kimmel Comprehensive Cancer Center.
-
Effects of Chemo on Cognitive Function
26/09/2012 Duración: 14minIn this podcast we discuss the long-term effects of chemotherapy on the cognitive function of cancer patients and the current status of research in this field.
-
ASCO Breast Cancer Symposium Recap
20/09/2012 Duración: 09minWe speak with Clifford Hudis, MD, Memorial Sloan-Kettering Cancer Center, about the recent advances in breast cancer treatment and the top news to come out of this year’s ASCO Breast Cancer Symposium.